Total Funding
53
Total FundingVenture - Series Unknown raised
Growth Score in past quarter
pts
Heat Score 53 in past quarter
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1160103
ImaRX Therapeutics is a biopharmaceutical company that develops and distributes stroke and vascular disorder therapies.
Acquired by 

Cerevast Therapeutics
About the Company
ImaRx Therapeutics is a research focused bio-pharmaceutical company engaged in development therapies for vascular disorders. The company develops therapies for stroke and other vascular disorders, using its proprietary micro bubble technology to treat vascular occlusions the resulting ischemia.

